← back to search

Jia Zhang

Shanghai University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, RNA modifications and cancer, and Circular RNAs in diseases.
h-index
34
citations
3,892
works
227
NIH funding
primary concept
email

Recent publications

Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7
Molecular Cancer 2023cited by 86position: middledoi
Cathepsin B S-nitrosylation promotes ADAR1-mediated editing of its own mRNA transcript via an ADD1/MATR3 regulatory axis
Cell Research 2023cited by 18position: middledoi
Additional file 1 of Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p/ATG2B/PTEN-AKT axis to mediate autophagy and pyroptosis
Open MIND 2023cited by 0position: middledoi
HSF2BP protects against acute liver injury by regulating HSF2/HSP70/MAPK signaling in mice
Cell Death and Disease 2022cited by 22position: middledoi
The mediating role of decision-making conflict in the association between patient’s participation satisfaction and distress during medical decision-making among Chinese patients with pulmonary nodules
Patient Education and Counseling 2022cited by 4position: middledoi
The correlation between trimethylamine N-oxide, lipoprotein ratios, and conventional lipid parameters in patients with unstable angina pectoris
Bioscience Reports 2020cited by 11position: middledoi
Inhibition of miR-19a protects neurons against ischemic stroke through modulating glucose metabolism and neuronal apoptosis
Cellular & Molecular Biology Letters 2019cited by 88position: middledoi
The modification of ovalbumin surface properties treated by pulsed electric field combined with divalent metal ions
Food Chemistry 2019cited by 27position: firstdoi
MicroRNA‑1 downregulation induced by carvedilol protects cardiomyocytes against apoptosis by targeting heat shock protein 60
Molecular Medicine Reports 2019cited by 21position: middledoi
Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals
Chinese Journal of Natural Medicines 2015cited by 131position: middledoi
Pyocyanin from Pseudomonas induces IL-8 production through the PKC and NF-κB pathways in U937 cells
Molecular Medicine Reports 2013cited by 7position: middledoi
Comparative Effects of Liensinine and Neferine on the Human Ether-a-go-go-related Gene Potassium Channel and Pharmacological Activity Analysis
Cellular Physiology and Biochemistry 2012cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zengxiang Dong · Georgetown University2 papers (2012–2020)Jing Wang · Shanxi Medical University1 papers (2022–2022)Dan Li · Xi'an Jiaotong University1 papers (2022–2022)Lu Liu · Soochow University1 papers (2019–2019)Chuan Li · Nanchang University1 papers (2015–2015)Yunfeng Zhang · Zhengzhou University1 papers (2023–2023)Ying Li · Luohe Medical College1 papers (2013–2013)Yanyan Liu · Fudan University1 papers (2019–2019)Yong Zhang · Inner Mongolia Agricultural University1 papers (2019–2019)Qian Wang · Northwest A&F University1 papers (2015–2015)Rui Wang · Houston Methodist1 papers (2023–2023)Baofeng Yang · Shenyang Pharmaceutical University1 papers (2012–2012)Liansheng Wang · Sun Yat-sen University1 papers (2023–2023)Xin Liu · Shenyang Agricultural University1 papers (2019–2019)Yurong Chen · Jinan University1 papers (2023–2023)Ye Sun · Guangzhou University of Chinese Medicine1 papers (2023–2023)Dapeng Liu · Zhejiang International Studies University1 papers (2023–2023)Xin Zhao · Chinese Academy of Sciences1 papers (2012–2012)Xiang Li · Army Medical University1 papers (2023–2023)Mingwei Chen · Anhui Medical University1 papers (2022–2022)